Skip to main content

Brain and CNS.

39 Phase 1 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Brain and CNS39 studies

Adult GlioblastomaPhase 1NCT04573140Papers

Autologous total tumor mRNA

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

University of FloridaOpen the brief

Glioblastoma (GBM)Phase 1/2NCT07346144Papers

TGX-007

An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Trogenix ltdOpen the brief

Recurrent GlioblastomaPhase 1NCT06815029

Chimeric Antigen Receptor T-Cell Therapy

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

City of Hope Medical CenterOpen the brief

Glioblastoma Multiforme of BrainPhase 1NCT06815432

15.GPC3-CAR T cells

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Baylor College of MedicineOpen the brief

EGFR-Altered IDH-Wildtype Glioblastoma or GliosarcomaPhase 1NCT07089641

EGFR Inhibitor ERAS-801

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Jonsson Comprehensive Cancer CenterOpen the brief

Currently Only Enrolling Glioblastoma Patients at First RecurrencePhase 1NCT05139056

Neural Stem Cells-expressing CRAd-S-pk7

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

City of Hope Medical CenterOpen the brief

Neoplasms, BrainPhase 1NCT03911388Papers

G207

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

M.D. Anderson Cancer CenterOpen the brief

Recurrent GlioblastomaPhase 1NCT07579208

NK Cells

Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

M.D. Anderson Cancer CenterOpen the brief

Low Grade Glioma of BrainPhase 1NCT05609994

PEPIDH1M vaccine + vorasidenib

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Katy Peters, MD, PhDOpen the brief

Newly Diagnosed GlioblastomaPhase 1NCT04903795

HEGFRvIII-CD3 (BRiTE)

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Mustafa Khasraw, MBChB, MD, FRCP, FRACPOpen the brief

Recurrent/Progressive Non-Enhancing IDH-Mutant GliomaPhase 1NCT03922555

ASTX727 for IDH-Mutant Glioma

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Massachusetts General HospitalOpen the brief

High Grade GliomaPhase 1NCT06428045Papers

STARLITE

STARLITE for Unresectable High-Grade Gliomas

University of MiamiOpen the brief

GliomaPhase 1NCT07541781

Sitagliptin

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Kailin Yang, MD, PhDOpen the brief

Recurrent Diffuse Hemispheric Glioma, H3 G34-MutantPhase 1NCT06914479

Ad-hCMV-Flt3L

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

University of Michigan Rogel Cancer CenterOpen the brief

Clinical trials: Phase 1 and Phase 2, explained